Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,951 INR | -0.35% | -1.63% | +1.21% |
Apr. 26 | Weak March Quarter Earnings Weigh Down Indian Equities on Friday | MT |
Apr. 25 | Divi's Laboratories Plans Up To INR7 Billion Investment to Boost Capacity | MT |
Sales 2024 * | 76.83B 921M | Sales 2025 * | 88.65B 1.06B | Capitalization | 1,049B 12.57B |
---|---|---|---|---|---|
Net income 2024 * | 15.4B 185M | Net income 2025 * | 20.4B 244M | EV / Sales 2024 * | 13.1 x |
Net cash position 2024 * | 46.03B 552M | Net cash position 2025 * | 48.33B 579M | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
67.8
x | P/E ratio 2025 * |
51.3
x | Employees | 8,433 |
Yield 2024 * |
0.67% | Yield 2025 * |
0.73% | Free-Float | 47.74% |
Latest transcript on Divi's Laboratories Limited
1 day | -0.35% | ||
1 week | -1.63% | ||
Current month | -1.29% | ||
1 month | +7.22% | ||
3 months | +6.80% | ||
6 months | +17.91% | ||
Current year | +1.21% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 01-08-09 | |
Founder | 73 | 90-10-11 | |
Director of Finance/CFO | 74 | 94-11-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 73 | 90-10-11 | |
Chief Executive Officer | 46 | 01-08-09 | |
Director/Board Member | - | 14-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.68% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3,951 | -0.35% | 348,122 |
24-05-02 | 3,965 | -0.94% | 868,450 |
24-04-30 | 4,002 | +0.33% | 360,469 |
24-04-29 | 3,989 | -0.67% | 752,787 |
24-04-26 | 4,016 | +4.49% | 1,155,173 |
Delayed Quote NSE India S.E., May 03, 2024 at 07:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.21% | 12.58B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- DIVISLAB Stock